Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

NCT05279846 is registered in ClinicalTrials.gov with Moberg Pharma AB as lead sponsor.

NCT NCT05279846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05279846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Lead sponsor
Moberg Pharma AB
Phase
Phase 3
Overall status
Unknown status
Start date
May 9, 2022
Completion date
January 31, 2025
Enrollment
350 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

onychomycosis